We seek wild precision for the Nutraceutical industry by developing pristine bioactive botanicals, using indoor farming.
BOTALYS has raised $3.4M in total funding. The most recent round was Convertible Note. The last funding was announced in November 2025.
BOTALYS's investors include The Yield Lab Europe, Vives Louvain Technology Fund, Teseo Capital, Horizon 2020, S.R.I.W..
BOTALYS is headquartered in Ghislenghien, Belgium.
We seek wild precision for the Nutraceutical industry by developing pristine bioactive botanicals, using indoor farming.
BOTALYS is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BOTALYS — Funding & Investors." VCBacked, November 21, 2025, https://www.vcbacked.co/company/botalys. Accessed August 1, 2026.
VCBacked. (2025). BOTALYS — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/botalys
{{cite web |title=BOTALYS — Funding & Investors |url=https://www.vcbacked.co/company/botalys |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated